New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Long-term NSAID use beneficial in knee osteoarthritis

Long-term NSAID use beneficial in knee osteoarthritis

(HealthDay)—For patients with knee osteoarthritis, long-term nonsteroidal anti-inflammatory drug (NSAID) use is associated with improvements in symptoms and disease progression, according to a study p
Arthritis and Rheumatism March 11,2024
Long-term NSAID use beneficial in knee osteoarthritis

Long-term NSAID use beneficial in knee osteoarthritis

(HealthDay)—For patients with knee osteoarthritis, long-term nonsteroidal anti-inflammatory drug (NSAID) use is associated with improvements in symptoms and disease progression, according to a study p
Arthritis and Rheumatism March 11,2024
Meta-analysis: Valgus knee bracing helps pain in knee OA

Meta-analysis: Valgus knee bracing helps pain in knee OA

(HealthDay)—For patients with knee osteoarthritis (OA), valgus knee bracing is associated with improvements in pain, according to a meta-analysis published in the April issue ofArthritis Care &a
Arthritis and Rheumatism March 11,2024
Meta-analysis: Valgus knee bracing helps pain in knee OA

Meta-analysis: Valgus knee bracing helps pain in knee OA

(HealthDay)—For patients with knee osteoarthritis (OA), valgus knee bracing is associated with improvements in pain, according to a meta-analysis published in the April issue ofArthritis Care &a
Arthritis and Rheumatism March 11,2024
Majority of fibromyalgia drug trials are industry sponsored

Majority of fibromyalgia drug trials are industry sponsored

(HealthDay)—Most fibromyalgia drug therapy randomized controlled trials (FM-RCTs) are funded by industry, and many authors have financial conflicts of interest (FCOIs), according to a study published
Arthritis and Rheumatism March 11,2024
Majority of fibromyalgia drug trials are industry sponsored

Majority of fibromyalgia drug trials are industry sponsored

(HealthDay)—Most fibromyalgia drug therapy randomized controlled trials (FM-RCTs) are funded by industry, and many authors have financial conflicts of interest (FCOIs), according to a study published
Arthritis and Rheumatism March 11,2024
Use of nondrug, nonsurgical options low in hip, knee OA

Use of nondrug, nonsurgical options low in hip, knee OA

(HealthDay)—Usage of nondrug, nonoperative interventions in community-dwelling individuals with hip and knee osteoarthritis (OA) is low, according to research published in the February issue ofA
Arthritis and Rheumatism March 11,2024
Use of nondrug, nonsurgical options low in hip, knee OA

Use of nondrug, nonsurgical options low in hip, knee OA

(HealthDay)—Usage of nondrug, nonoperative interventions in community-dwelling individuals with hip and knee osteoarthritis (OA) is low, according to research published in the February issue ofA
Arthritis and Rheumatism March 11,2024
Combined patient, physician intervention ups function in OA

Combined patient, physician intervention ups function in OA

(HealthDay)—For patients with hip and knee osteoarthritis, a combined patient and provider intervention is associated with modest improvements in function, according to a study published online Dec. 2
Arthritis and Rheumatism March 11,2024
Combined patient, physician intervention ups function in OA

Combined patient, physician intervention ups function in OA

(HealthDay)—For patients with hip and knee osteoarthritis, a combined patient and provider intervention is associated with modest improvements in function, according to a study published online Dec. 2
Arthritis and Rheumatism March 11,2024
Lifestyle intervention can ward off obesity-related knee pain

Lifestyle intervention can ward off obesity-related knee pain

(HealthDay)—For overweight adults with diabetes mellitus, an intensive lifestyle intervention (ILI) can prevent knee pain, according to a study published in the July issue ofArthritis Care &
Arthritis and Rheumatism March 11,2024
Lifestyle intervention can ward off obesity-related knee pain

Lifestyle intervention can ward off obesity-related knee pain

(HealthDay)—For overweight adults with diabetes mellitus, an intensive lifestyle intervention (ILI) can prevent knee pain, according to a study published in the July issue ofArthritis Care &
Arthritis and Rheumatism March 11,2024
Lymph node research pioneers’ new approach to vaccine design for the most vulnerable

Lymph node research pioneers’ new approach to vaccine design for the most vulnerable

17 January 2024The Oxford Experimental Medicine Clinical Research Facility (EMCRF) at NDORMS has received its first volunteers as part of the LEGACY03 trial to improve vaccine design for different age
Breakthroughs March 11,2024
Lymph node research pioneers’ new approach to vaccine design for the most vulnerable

Lymph node research pioneers’ new approach to vaccine design for the most vulnerable

17 January 2024The Oxford Experimental Medicine Clinical Research Facility (EMCRF) at NDORMS has received its first volunteers as part of the LEGACY03 trial to improve vaccine design for different age
Breakthroughs March 11,2024
Can you use rapid antigen tests in children under two years old?

Can you use rapid antigen tests in children under two years old?

by Thea Van de Mortel and Karin Plummer,The ConversationCredit: AI-generated imageAs we head into winter, you may have a sniffly child under two years old at home. Is it just a cold? Or could it
Pediatrics March 11,2024
Can you use rapid antigen tests in children under two years old?

Can you use rapid antigen tests in children under two years old?

by Thea Van de Mortel and Karin Plummer,The ConversationCredit: AI-generated imageAs we head into winter, you may have a sniffly child under two years old at home. Is it just a cold? Or could it
Pediatrics March 11,2024
High physical activity does not offset obesity risk among preteens with high screen time

High physical activity does not offset obesity risk among preteens with high screen time

by University of TorontoAssociations Between Screen Time and Step Count Category Combinations and Body Mass Index (BMI) Percentile. Results correspond to coefficients from a linear regression mod
Pediatrics March 11,2024
High physical activity does not offset obesity risk among preteens with high screen time

High physical activity does not offset obesity risk among preteens with high screen time

by University of TorontoAssociations Between Screen Time and Step Count Category Combinations and Body Mass Index (BMI) Percentile. Results correspond to coefficients from a linear regression mod
Pediatrics March 11,2024
CDC recommends RSV shot for all infants

CDC recommends RSV shot for all infants

by Cara MurezThe U.S. Centers for Disease Control and Prevention on Thursday recommended that all infants under the age of 8 months be given a new antibody shot to help guard against severe respirator
Pediatrics March 11,2024
CDC recommends RSV shot for all infants

CDC recommends RSV shot for all infants

by Cara MurezThe U.S. Centers for Disease Control and Prevention on Thursday recommended that all infants under the age of 8 months be given a new antibody shot to help guard against severe respirator
Pediatrics March 11,2024
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com